Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€72.00

€72.00

-1.330%
-1.0
-1.330%
€76.78
 
11.12.25 / Tradegate WKN: 881782 / Symbol: HAE / Name: Haemonetics / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Haemonetics Corp. is only available for our menbers.
Not a member yet? Sign up for free!

Financial data and news for Haemonetics

sharewise wants to provide you with the best news and tools for Haemonetics, so we directly link to the best financial data sources.

News

SG Capital Dumps Nearly 732,000 Haemonetics Shares Worth $59.1 Million: https://g.foolcdn.com/misc-assets/institutional.png
SG Capital Dumps Nearly 732,000 Haemonetics Shares Worth $59.1 Million

SG Capital Management LLC reduced its holding in Haemonetics Corporation (NYSE:HAE) by 731,892 shares, a position value decline of $59,133,712, per November 07, 2025, SEC filings.

According to a fil

Why Haemonetics Stock Was on Fire Thursday: https://g.foolcdn.com/editorial/images/841729/person-in-a-lab-gazing-into-a-microscope.jpg
Why Haemonetics Stock Was on Fire Thursday

Niche healthcare stock Haemonetics (NYSE: HAE) was a winner among the clutch of publicly traded companies reporting quarterly earnings on Thursday. On the back of an estimates-beating second quarter